Jerome M. Hauer is Director at Emergent BioSolutions Inc. (EBS). They have made 14 open-market trades across 1 company since 2010, most recently 2023-05-25.
CIK 0001294935
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 14 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EBS | 57,508 | $367K |
Shares reported on the most recent Form 4, priced at the 2023-05-30 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EBS | SELL | 2020-05-26 | 2020-05-27 | $85.15 | $747K | -18.4% | -10.5% | +46.9% |
| EBS | SELL | 2020-02-21 | 2020-02-25 | $70.00 | $460K | -2.4% | -4.5% | +39.9% |
| EBS | SELL | 2018-06-05 | 2018-06-07 | $52.16 | $437K | +1.7% | +1.2% | +12.9% |
| EBS | SELL | 2018-01-22 | 2018-01-24 | $50.69 | $784K | -10.1% | -5.1% | +7.4% |
| EBS | SELL | 2017-08-15 | 2017-08-17 | $35.83 | $772K | +2.7% | +7.8% | +9.2% |
| EBS | SELL | 2017-03-08 | 2017-03-10 | $31.27 | $161K | -5.2% | -7.3% | +2.5% |
| EBS | SELL | 2016-05-19 | 2016-05-23 | $41.22 | $258K | +3.9% | -25.5% | -67.0% |
| EBS | SELL | 2016-05-12 | 2016-05-16 | $38.50 | $181K | +5.7% | +0.9% | -66.4% |
| EBS | SELL | 2016-03-14 | 2016-03-16 | $33.88 | $80K | +8.3% | +20.7% | +27.4% |
| EBS | SELL | 2015-05-26 | 2015-05-28 | $30.54 | $15K | -12.7% | -2.9% | -2.9% |
| EBS | SELL | 2011-06-07 | 2011-06-09 | $24.00 | $115K | -12.7% | -2.9% | -2.9% |
| EBS | SELL | 2010-11-17 | 2010-11-19 | $18.19 | $672K | -12.7% | -2.9% | -2.9% |
| EBS | SELL | 2010-05-17 | 2010-05-18 | $16.90 | $253K | -12.7% | -2.9% | -2.9% |
| EBS | SELL | 2010-03-09 | 2010-03-11 | $15.82 | $316K | -12.7% | -2.9% | -2.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.